National Institute of Allergy and Infectious Diseases



	Advanced Search

News & Events
News Releases
Qs & As
Media Inquiries
Events & Calendars
Calendars
Commemorative Days
HIV Vaccine Awareness Day
Meetings and Lectures
US-Japan Viral Immunology Symposium
Vaccine Research Seminars
NIAID in the News
Resources

Vaccines for Viral Infections in Developing Countries

Agenda

Thursday, July 27, 2006

8:50 AM	Opening Remarks Diane Griffin, Johns Hopkins University, USA Harry Greenberg, Stanford University, USA
9:00 AM	Overview and Major Issues for Assessment of Disease Burden of Viral Diseases in Asia Hitoshi Oshitani, Tohoku University, Japan

Rotavirus Session

9:45 AM Epidemiology Of Rotavirus Infection And The Need For A Vaccine In Asia
Tony Nelson, The Chinese University of Hong Kong, China

10:15 AM Development and Implementation of Vaccine Made in the Third World
R. Bhan, New Delhi, India

10:45 AM Break

11:00 AM Outlook for the Implementation of a Human-Bovine (UK) Rotavirus Reassortant Vaccine
Al Kapikian, NIH, USA

11:30 AM
Development and Commercial Manufacturing Challenges for Live Attenuated Rotavirus Vaccines
W. Wainwright, Path and NIH, USA

12:00 PM Phase III Clinical Results of Rotavirus Vaccine Trials and Efforts to Accelerate Introduction to the Developing World
John Boslego, Path, USA

12:30 PM Lunch

Human Papillomavirus Session

1:30 PM Human Papillomavirus Vaccination for Cervical Cancer Prevention
Patti Gravitt, Johns Hopkins University, USA

2:00 PM Issues Regarding Marketing and Distribution of Vaccines in Developing Countries
Elaine Esber, Merck, USA

2:30 PM Development of Human Papillomavirus Vaccine Against a Broader Spectrum of Oncogenic Types
Tadahito Kanda, Japan

Rabiesvirus Session

3:00 PM	Rabies Epidemiology, Disease Burden and Vaccine Utilization in Asia Elizabeth Miranda, Phillipines
3:30 PM	Break
3:45 PM	Current Vaccines and Their Availability in China Zhen Fu, University of Georgia, USA
4:15 PM	Control of Rabies in Asia Requires Quality Biologicals and the Motivation to Use Them Appropriately Henry Wilde, Thai Red Cross
4:45 PM	Adjourn
6:30- 8:30 PM	Reception

Friday, July 28, 2006

Japanese Encephalitis Session

9:00 AM	Strategy for Introduction of JE Vaccine Into Routine Immunization Julie Jacobson, Path, USA
9:30 AM	Disease Burden Due to Japanese Encephalitis (JE) and Cost-Effectiveness of JE Immunization in Asia Zhi-Yi Xu, IVI, Seoul
10:00 AM	Continued Transmission and Need for Booster Doses in An Endemic Country Eiji Konishi, Kobe University, Japan
10:30 AM	Break
10:45 AM	Immunological Surrogates for Japanese Encephalitis Vaccine-Induced Protection Ichiro Kurane, NIH Japan
11:15 AM	Developing a New JE Vaccine–Switch the Mouse Brain to the Vero Cell Shigeharu Ueda, BIKEN Foundation, Japan
11:45 AM	Inactivated SA14-14-2 Erich Tauber, Intercell, AG
12:15 PM	Lunch
1:30 PM	Safety and Efficacy of Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 in Human Vaccination Yu Yongxin, NICBP, Beijing
2:00 PM	Chimerivax^TM – A Platform Technology for Flavivirus Vaccine Development – Status of a New Vaccine Against Japanese Encephalitis Niranjan Kanesa-thasan, Acambis, USA

Influenza Session

2:30 PM	Emergence and Continuing Evolution of H5N1 Influenza Robert Webster, St. Jude Hospital, USA
3:00 PM	Vaccine Development for Pandemic and Seasonal Influenza John Treanor, University of Rochester Medical Center, USA
3:30 PM	Break
3:45 PM	Influenza in Asia Hiroshi Suzuki, Niigata University, Japan
4:15 PM	Influenza Virus Patterns in Asia Mark Steinhoff, Johns Hopkins University, USA
4:45 PM	Development Of Human Influenza H5N1 Vaccines In Japan: Research And Clinical Trials Masato Tashiro, National Institute of Infectious Diseases, Japan
5:15 PM	Closing Remarks Akira Oya, National Institute of Infectious Diseases, Japan

Participant List (PDF)